RXO, Inc.
RXO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,181 | $2,718 | $2,002 | $2,444 |
| - Cash | $35 | $5 | $98 | $29 |
| + Debt | $664 | $558 | $617 | $135 |
| Enterprise Value | $3,810 | $3,271 | $2,521 | $2,550 |
| Revenue | $4,550 | $3,927 | $4,796 | $4,689 |
| % Growth | 15.9% | -18.1% | 2.3% | – |
| Gross Profit | $783 | $725 | $860 | $735 |
| % Margin | 17.2% | 18.5% | 17.9% | 15.7% |
| EBITDA | $117 | $134 | $209 | $272 |
| % Margin | 2.6% | 3.4% | 4.4% | 5.8% |
| Net Income | -$290 | $4 | $92 | $150 |
| % Margin | -6.4% | 0.1% | 1.9% | 3.2% |
| EPS Diluted | -2.17 | 0.034 | 0.79 | 1.29 |
| % Growth | -6,577.6% | -95.8% | -38.8% | – |
| Operating Cash Flow | -$12 | $89 | $310 | $155 |
| Capital Expenditures | -$45 | -$64 | -$57 | -$39 |
| Free Cash Flow | -$57 | $25 | $253 | $116 |